Anti-vaxxers’ false claim on SA news site debunked
Contrary to misinformation, the first dose of the Pfizer vaccine does give you protection against Covid, and a second dose gives even more.
First published by GroundUp.
A South African news site, Biznews, that has become notorious for promoting misinformation about Covid, has published an article that makes numerous misleading and false claims.
Biznews is not a member of the South African Press Council and therefore not subject to press ombudsman complaints or rulings.
The Biznews article explicitly states that immediately after being vaccinated with the first dose people are placed at greater risk of contracting Covid. The article specifically mentions the Pfizer and AstraZeneca vaccines in this regard. (Since the Pfizer vaccine is being used in South Africa, we deal only with that here.)
The claim is nonsense and it is firmly debunked by a study published in the world’s leading medical journal, the New England Journal of Medicine, last week. The study authors are the scientists who tested the BioNTech/Pfizer vaccine. This is the most widely used vaccine in South Africa. The study presents the six-month data of the clinical trial that found this vaccine to be safe and effective.
The Pfizer vaccine protocol involves having two doses several weeks apart.
The trial volunteers were randomly divided into two nearly equally sized groups: those who got the vaccine and those who got a placebo (a harmless substance that does nothing).
Between the first and second dose on the trial, 110 people on the placebo contracted Covid versus 46 vaccine recipients. This is a first dose vaccine efficacy of 58%. It’s not nearly as effective as efficacy after the second dose but it thoroughly debunks the myth that after the first shot you’re at greater risk of Covid.
Moreover, 30 of the 31 people on the trial who got severe Covid were in the placebo group. This thoroughly refutes the idea that you’re more at risk of Covid after your first dose.
Another important finding from the study was that vaccine efficacy against Covid was over 91% through six months of follow-up, albeit that there was a gradual decline in vaccine efficacy with time. “Vaccine efficacy against severe disease was 96.7%” the paper states. In South Africa, the vaccine was 100% effective over the duration of the study, though this was while the beta variant was dominant. Since then, the delta variant has become dominant here.
The authors concluded: “Through six months of follow-up and despite a gradual decline in … efficacy, [the vaccine] had a favourable safety profile and was highly efficacious in preventing Covid-19.”
Watch this video which explains how we know if vaccines and medicines are safe and effective:
"Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email [email protected]"